Cordis says district judge upholds patent infringement verdicts against Boston Scientific, Medtronic

New York, March 27 - Cordis Corp. said that U.S. district judge Sue Robinson upheld two March 2005 jury verdicts that patents for balloon expandable stents were valid and infringed by Boston Scientific Corp. and Medtronic, Inc.

The juries found Boston Scientific's NIR stent infringed Cordis' Palmaz patent and Medtronic's GFX and Microstent II infringed both the Palmaz and Schatz patents.

A decision on damages has been deferred, Cordis said in a news release.

Cordis is a Miami-based subsidiary of Johnson & Johnson.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.